Cargando…
Artemisinins as Anticancer Drugs: Novel Therapeutic Approaches, Molecular Mechanisms, and Clinical Trials
Artemisinin and its derivatives have shown broad-spectrum antitumor activities in vitro and in vivo. Furthermore, outcomes from a limited number of clinical trials provide encouraging evidence for their excellent antitumor activities. However, some problems such as poor solubility, toxicity and cont...
Autores principales: | Xu, Cangcang, Zhang, Huihui, Mu, Lingli, Yang, Xiaoping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573816/ https://www.ncbi.nlm.nih.gov/pubmed/33117153 http://dx.doi.org/10.3389/fphar.2020.529881 |
Ejemplares similares
-
Repurposing Artemisinin and its Derivatives as Anticancer Drugs: A Chance or Challenge?
por: Ma, Zhaowu, et al.
Publicado: (2021) -
Anti-Melanoma Activities of Artemisone and Prenylated Amino-Artemisinins in Combination With Known Anticancer Drugs
por: Wong, Ho Ning, et al.
Publicado: (2020) -
Novel dihydroartemisinin derivative Mito-DHA(5) induces apoptosis associated with mitochondrial pathway in bladder cancer cells
por: Xiao, Linfan, et al.
Publicado: (2022) -
The Role of Nrf2 in Liver Disease: Novel Molecular Mechanisms and Therapeutic Approaches
por: Xu, Dongwei, et al.
Publicado: (2019) -
The Therapeutic Effect of Artemisinin and Its Derivatives in Kidney Disease
por: Xia, Ming, et al.
Publicado: (2020)